powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1013395730
Matthew Katz
M.D.
Urology
New York,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (2)
CCN 330204
Hospital
CCN 330214
Hospital
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$3K
Payment records
21
By payment type
Consulting Fee
$2K
Food and Beverage
$1K
Top paying entities
Consulting Fee
$2K
Food and Beverage
$1K
PRESCRIBING · PART D · 2024
Total Rx claims
479
Beneficiaries
—
Total drug cost
$67K
Distinct drugs
12
Brand share
35.1%
Top prescribed drugs
Tamsulosin Hcl
191 claims
Finasteride
50 claims
Vibegron
49 claims
Mirabegron
38 claims
Alfuzosin Hcl
30 claims
QUALITY · MIPS · 2024
Final MIPS score
90.8
Quality
91.8
Cost
75.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.66%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
765
Unique beneficiaries
—
Total services
964
Distinct HCPCS
11
Medicare payment
$100K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 756 Urology providers in NY — below median (cohort median 1,574).
